gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bishop, D; Cho, HR; Choi, SH; Doble, P; Hare, D; Jung, HS; Kim, KG; Kim, YJ; Lee, Y; Moon, WK; Park, KS | 1 |
| Bonnet, PA; Chambon, C; Doucet, D; Fernandez, JP; Michel, A | 1 |
2 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Alloxan Diabetes
| Article | Year |
|---|---|
Magnetic resonance imaging of the pancreas in streptozotocin-induced diabetic rats: Gadofluorine P and Gd-DOTA.
Topics: Animals; Area Under Curve; Biopsy; Contrast Media; Coordination Complexes; Diabetes Mellitus, Experimental; Female; Fluorocarbons; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Pancreas; Predictive Value of Tests; Rats, Inbred F344; ROC Curve; Time Factors | 2015 |
Pharmacokinetic study of gadolinium-DOTA in control and streptozocin diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Heterocyclic Compounds; Injections, Intravenous; Male; Organometallic Compounds; Rats; Rats, Wistar | 1992 |